CH Term (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.5.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-term/ and changes regularly. See the Directory of published versions
| Official URL: http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-ch-vaccination-plan-immunizations-vs | Version: 3.5.0-ci-build | ||||
| Active as of 2026-10-13 | Computable Name: SwissVaccinationPlanImmunizations | ||||
Copyright/Legal: CC0-1.0 |
|||||
Immunization procedures for recommendations according to the vaccination plan.
References
Detailed information about the current version of this artifact, including cross-references to resources that use it, can be found here via the XIG (Cross-IG) index for FHIR specifications.
http://snomed.info/sct version Not Stated (use latest from terminology server)| Code | Display |
| 42284007 | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) |
| 76668005 | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) |
| 127787002 | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) |
| 243789007 | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) |
| 16584000 | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) |
| 86198006 | Administration of vaccine product containing only Influenza virus antigen (procedure) |
| 314759000 | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) |
| 47435007 | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) |
| 719596001 | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) |
| 314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) |
| 871874000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) |
| 50583002 | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) |
| 761841000 | Administration of vaccine product containing only Human papillomavirus antigen (procedure) |
| 39343008 | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) |
| 1119368005 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) |
| 1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) |
| 1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) |
| 72093006 | Administration of vaccine product containing only Human poliovirus antigen (procedure) |
| 34631000 | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) |
| 82314000 | Administration of vaccine product containing only Rubella virus antigen (procedure) |
| 127786006 | Administration of vaccine product containing only Clostridium tetani antigen (procedure) |
| 281658005 | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) |
| 15483003 | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) |
| 737081007 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) |
| 722215002 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) |
| 67308009 | Administration of vaccine product containing only Yellow fever virus antigen (procedure) |
| 1157107003 | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) |
| 1119350007 | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) |
| 1209198003 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) |
| 1162645008 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) |
Expansion from tx.fhir.ch based on SNOMED CT Swiss Edition edition 07-Jun 2026
This value set contains 30 concepts
| System | Code | Display (en) | Inactive | status | JSON | XML |
http://snomed.info/sct | 42284007 | BCG vaccination | ||||
http://snomed.info/sct | 76668005 | Administration of diphtheria vaccine | ||||
http://snomed.info/sct | 127787002 | Administration of Haemophilus influenzae type b vaccine | ||||
http://snomed.info/sct | 243789007 | Administration of hepatitis A vaccine | ||||
http://snomed.info/sct | 16584000 | Administration of hepatitis B vaccine | ||||
http://snomed.info/sct | 86198006 | Administration of influenza vaccine | ||||
http://snomed.info/sct | 314759000 | Administration of Japanese encephalitis vaccine | ||||
http://snomed.info/sct | 47435007 | Administration of measles vaccine | ||||
http://snomed.info/sct | 719596001 | Administration of meningitis C vaccine | ||||
http://snomed.info/sct | 314417000 | Administration of meningitis A and C vaccine | ||||
http://snomed.info/sct | 871874000 | Administration of meningitis A, C, W135 and Y vaccine | ||||
http://snomed.info/sct | 50583002 | Administration of mumps vaccine | ||||
http://snomed.info/sct | 761841000 | Administration of human papilloma virus vaccine | ||||
http://snomed.info/sct | 39343008 | Administration of pertussis vaccine | ||||
http://snomed.info/sct | 1119368005 | Administration of pneumococcal 7-valent conjugate vaccine | ||||
http://snomed.info/sct | 1119366009 | Administration of pneumococcal 13-valent conjugate vaccine | inactive | inactive | ||
http://snomed.info/sct | 1119367000 | Administration of pneumococcal 23-valent vaccine | ||||
http://snomed.info/sct | 72093006 | Administration of poliomyelitis vaccine | ||||
http://snomed.info/sct | 34631000 | Administration of rabies vaccine | ||||
http://snomed.info/sct | 82314000 | Administration of rubella vaccine | ||||
http://snomed.info/sct | 127786006 | Administration of tetanus vaccine | ||||
http://snomed.info/sct | 281658005 | Administration of tick-borne encephalitis vaccine | ||||
http://snomed.info/sct | 15483003 | Administration of typhoid vaccine | ||||
http://snomed.info/sct | 737081007 | Administration of Varicella-zoster vaccine for chickenpox | ||||
http://snomed.info/sct | 722215002 | Administration of Varicella-zoster vaccine for shingles | ||||
http://snomed.info/sct | 67308009 | Administration of yellow fever vaccine | ||||
http://snomed.info/sct | 1157107003 | Administration of SARS-CoV-2 non-replicating viral vector vaccine | ||||
http://snomed.info/sct | 1119350007 | Administration of SARS-CoV-2 mRNA vaccine | ||||
http://snomed.info/sct | 1209198003 | Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | ||||
http://snomed.info/sct | 1162645008 | Administration of SARS-CoV-2 recombinant spike protein antigen vaccine |
Additional Designations and Language Displays
| Code | Preferred For Language | Deutsch (German, de) | English (English, en) | French (fr) | Italian (it) |
| 42284007 | Administration of vaccine product containing only live attenuated Mycobacterium bovis antigen (procedure) | Verabreichung einer Impfung gegen Mycobakterium bovis | BCG vaccination | vaccination par le BCG | vaccinazione contro la tubercolosi |
| 76668005 | Administration of vaccine product containing only Corynebacterium diphtheriae antigen (procedure) | Verabreichung einer Impfung gegen Corynebacterium diphtheriae | Administration of diphtheria vaccine | vaccination contre la diphtérie | vaccinazione contro la difterite |
| 127787002 | Administration of vaccine product containing only Haemophilus influenzae type B antigen (procedure) | Verabreichung eines Impfstoffs gegen Haemophilus influenzae Typ B | Administration of Haemophilus influenzae type b vaccine | vaccination contre l'Haemophilus influenzae de type B | vaccinazione contro l'Haemophilus influenzae di tipo b |
| 243789007 | Administration of vaccine product containing only Hepatitis A virus antigen (procedure) | Verabreichung einer Impfung gegen Hepatitis-A-Virus | Administration of hepatitis A vaccine | immunisation contre l'hépatite A | vaccinazione contro l'epatite A |
| 16584000 | Administration of vaccine product containing only Hepatitis B virus antigen (procedure) | Verabreichung einer Impfung gegen Hepatitis-B-Virus | Administration of hepatitis B vaccine | vaccination contre l'hépatite B | vaccinazione contro l'epatite B |
| 86198006 | Administration of vaccine product containing only Influenza virus antigen (procedure) | Grippe-Impfung | Administration of influenza vaccine | vaccination contre l'influenza | vaccinazione contro l'influenza |
| 314759000 | Administration of vaccine product containing only Japanese encephalitis virus antigen (procedure) | Verabreichung einer Impfung gegen Japan-Encephalitis-Virus | Administration of Japanese encephalitis vaccine | vaccination contre l'encéphalite japonaise | Jvaccinazione contro l'encefalite giapponese |
| 47435007 | Administration of vaccine product containing only Measles morbillivirus antigen (procedure) | Verabreichung einer Impfung gegen Masernvirus | Administration of measles vaccine | vaccination antirougeoleuse | vaccinazione contro il morbillo |
| 719596001 | Administration of vaccine product containing only Neisseria meningitidis serogroup C antigen (procedure) | Verabreichung einer Impfung gegen Meningokokken C | Administration of meningitis C vaccine | vaccination contre la méningite C | vaccinazione contro la meningite C |
| 314417000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A and C antigens (procedure) | Verabreichung einer Impfung gegen Meningokokken A und C | Administration of meningitis A and C vaccine | vaccination contre les méningites A et C | vaccinazione contro la meningite A e C |
| 871874000 | Administration of vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (procedure) | Verabreichung einer Impfung gegen Meningokokken A, C, W135 und Y | Administration of meningitis A, C, W135 and Y vaccine | vaccination contre les méningites A, C, W135 et Y | vaccinazione contro la meningite A, C, W135 e Y |
| 50583002 | Administration of vaccine product containing only Mumps orthorubulavirus antigen (procedure) | Verabreichung einer Impfung gegen Mumpsvirus | Administration of mumps vaccine | vaccination contre les oreillons | vaccinazione contro la parotite |
| 761841000 | Administration of vaccine product containing only Human papillomavirus antigen (procedure) | Verabreichung einer Impfung gegen humanes Papillomavirus | Administration of human papilloma virus vaccine | vaccination contre le papillomavirus humain | vaccinazione contro il virus del papilloma umano |
| 39343008 | Administration of vaccine product containing only Bordetella pertussis antigen (procedure) | Pertussis-Impfung | Administration of pertussis vaccine | vaccination contre la coqueluche | vaccinazione contro la pertosse |
| 1119368005 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (procedure) | Verabreichung einer 7-valenten Konjugatimpfung gegen Pneumokokken | Administration of pneumococcal 7-valent conjugate vaccine | vaccination antipneumococcique conjugué 7-valent | vaccinazione con vaccino coniugato eptavalente contro gli pneumococchi |
| 1119366009 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (procedure) | Verabreichung einer 13-valenten Konjugatimpfung gegen Pneumokokken | Administration of pneumococcal 13-valent conjugate vaccine | vaccination antipneumococcique conjugué 13-valent | vaccinazione con vaccino coniugato 13-valente contro gli pneumococchi |
| 1119367000 | Administration of vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens (procedure) | Verabreichung einer 23-valenten Konjugatimpfung gegen Pneumokokken | Administration of pneumococcal 23-valent vaccine | vaccination antipneumococcique conjugué 23-valent | vaccinazione con vaccino coniugato 23-valente contro gli pneumococchi |
| 72093006 | Administration of vaccine product containing only Human poliovirus antigen (procedure) | Verabreichung eines Impfstoffs gegen Poliomyelitis | Administration of poliomyelitis vaccine | vaccination contre la poliomyélite | vaccinazione contro la poliomielite |
| 34631000 | Administration of vaccine product containing only Rabies lyssavirus antigen (procedure) | Verabreichung eines Impfstoffs gegen Tollwutvirus | Administration of rabies vaccine | vaccination contre la rage | vaccinazione contro la rabbia |
| 82314000 | Administration of vaccine product containing only Rubella virus antigen (procedure) | Verabreichung einer Impfung gegen Rötelnvirus | Administration of rubella vaccine | vaccination contre la rubéole | vaccinazione contro la rosolia |
| 127786006 | Administration of vaccine product containing only Clostridium tetani antigen (procedure) | Verabreichung eines Impfstoffs gegen Tetanus | Administration of tetanus vaccine | vaccination contre le tétanos | vaccinazione contro il tetano |
| 281658005 | Administration of vaccine product containing only Tick-borne encephalitis virus antigen (procedure) | Verabreichung einer Impfung gegen FSME-Virus | Administration of tick-borne encephalitis vaccine | vaccination contre l'encéphalite à tiques | vaccinazione contro la meningoencefalite da zecche |
| 15483003 | Administration of vaccine product containing only Salmonella enterica subspecies enterica serovar Typhi antigen (procedure) | Verabreichung einer Impfung gegen Salmonella enterica Serotyp Typhi | Administration of typhoid vaccine | vaccination antityphoïdique | vaccinazione contro la febbre tifoidea |
| 737081007 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for chickenpox (procedure) | Verabreichung einer Impfung gegen Varizella-Zoster-Virus bei Windpocken | Administration of Varicella-zoster vaccine for chickenpox | vaccination varicelle-zona contre la varicelle | vaccinazione contro il virus varicella-zoster: solo varicella |
| 722215002 | Administration of vaccine product containing only Human alphaherpesvirus 3 antigen for shingles (procedure) | Verabreichung einer Impfung gegen Varizella-Zoster-Virus bei Gürtelrose | Administration of Varicella-zoster vaccine for shingles | vaccination varicelle-zona contre le zona | vaccinazione contro il virus varicella-zoster: solo herpes zoster |
| 67308009 | Administration of vaccine product containing only Yellow fever virus antigen (procedure) | Verabreichung einer Impfung gegen Gelbfiebervirus | Administration of yellow fever vaccine | vaccination contre la fièvre jaune | vaccinazione contro la febbre gialla |
| 1157107003 | Administration of vaccine product containing only recombinant non-replicating viral vector encoding Severe acute respiratory syndrome coronavirus 2 spike protein (procedure) | Verabreichung einer nicht replizierenden Vektorimpfung gegen Coronavirus | Administration of SARS-CoV-2 non-replicating viral vector vaccine | administration d'un vaccin à vecteur viral recombinant non répliquant exprimant la protéine Spike du SARS-CoV-2 | vaccinazione con vaccino a vettore virale non replicante anti-COVID-19 |
| 1119350007 | Administration of vaccine product containing only Severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (procedure) | Verabreichung einer mRNA-Impfung gegen Coronavirus | Administration of SARS-CoV-2 mRNA vaccine | administration d'un vaccin à ARNm du SRAS-CoV-2 | vaccinazione con vaccino a mRNA anti-COVID-19 |
| 1209198003 | Administration of vaccine product containing only Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 antigen (procedure) | Verabreichung einer Impfung gegen die humanen Papillomaviren 6, 11, 16, 18, 31, 33, 45, 52 und 58 | Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine | vaccination contre le papillomavirus humain 6, 11, 16, 18, 31, 33, 45, 52 et 58 | vaccinazione contro i papillomavirus umani 6, 11, 16, 18, 31, 33, 45, 52 e 58 |
| 1162645008 | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) | Verabreichung einer Impfung gegen Coronavirus 2 mit rekombinanten Spike-Protein-Antigenen | Administration of SARS-CoV-2 recombinant spike protein antigen vaccine | administration d'un vaccin à protéine recombinante Spike du SARS-CoV-2 | vaccinazione con vaccino antigenico anti-COVID-19 con proteina spike ricombinante |